MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
AVROBIO EV - Enterprise Value 2011-2026 | AVRO
Annual EV - Enterprise Value AVROBIO
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -35.4 M | -9.31 M | -155 M | 279 M | 394 M | 59 M | 24.2 M | 9.98 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 394 M | -155 M | 70.7 M |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M |  Canada |
 |
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | USA |
 |
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | USA |
 |
Adagene
ADAG
|
395 M | $ 2.81 | -3.61 % | $ 158 M |  China |
 |
Biogen
BIIB
|
28.3 B | $ 176.6 | 0.24 % | $ 25.7 B | USA |
 |
BioNTech SE
BNTX
|
-6.64 B | $ 114.69 | -1.78 % | $ 27.2 B | Germany |
 |
ANI Pharmaceuticals
ANIP
|
1.91 B | $ 80.99 | -1.23 % | $ 1.56 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | USA |
 |
Amgen
AMGN
|
145 B | $ 340.73 | -0.64 % | $ 183 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
725 M | - | - | $ 1.01 B | USA |
 |
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M |  France |
 |
Burford Capital Limited
BUR
|
3.22 B | $ 9.61 | -0.47 % | $ 1.53 B |  Britain |
 |
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
Aytu BioScience
AYTU
|
-15.2 M | $ 2.59 | 0.39 % | $ 16.3 M | USA |
 |
CASI Pharmaceuticals
CASI
|
1.08 B | $ 0.99 | -0.01 % | $ 135 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.25 | -0.35 % | $ 7.82 B |  Australia |
 |
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | USA |
 |
Catalyst Biosciences
CBIO
|
38.1 M | $ 9.72 | -4.19 % | $ 640 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
-14.1 M | - | 3.16 % | $ 1.9 M | USA |
 |
Cerus Corporation
CERS
|
425 M | $ 2.25 | -3.02 % | $ 415 M | USA |
 |
Aptose Biosciences
APTO
|
10.8 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | USA |
 |
Cellectis S.A.
CLLS
|
109 M | $ 3.91 | -2.03 % | $ 116 M | France |
 |
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | USA |
 |
Beam Therapeutics
BEAM
|
2.59 B | $ 28.22 | -3.65 % | $ 2.32 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
726 M | $ 223.02 | -0.42 % | $ 5 B |  Danmark |
 |
Athira Pharma
ATHA
|
-18.3 M | - | - | $ 269 M | USA |
 |
Atreca
BCEL
|
94.8 M | - | -11.76 % | $ 5.79 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
2.05 B | $ 24.39 | -0.77 % | $ 2.89 B | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
6.02 B | $ 68.44 | -0.98 % | $ 9.15 B | USA |
 |
Cardiff Oncology
CRDF
|
157 M | $ 1.69 | 4.77 % | $ 80.5 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.52 M | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
6.28 M | - | -10.17 % | $ 12.2 K | USA |
 |
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-9.74 M | - | -9.72 % | $ 5.89 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
2.15 B | - | -15.15 % | $ 60.3 M | Britain |
 |
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 4.04 | -1.5 % | $ 8.79 B |  Israel |
 |
Amneal Pharmaceuticals
AMRX
|
1.72 B | $ 13.91 | -1.45 % | $ 4.3 B | USA |
 |
AIkido Pharma
AIKI
|
22.8 M | - | 1.93 % | $ 17.4 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
77.1 M | - | -74.18 % | $ 955 K | USA |
 |
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | USA |